Ontology highlight
ABSTRACT: Background
Cytomegalovirus (CMV) is one of the most important opportunistic infections in transplant recipients. Currently sero-positivity for CMV IgG before solid organ transplantation is the laboratory test of choice for stratifying the risk of CMV reactivation after solid organ transplantation. Theoretically, CMV-specific cell-mediated immune responses before solid organ transplantation should further categorize patients as high or low risk of CMV development. We therefore evaluated the usefulness of the CMV-specific enzyme-linked immunospot (ELISPOT) assay in kidney transplant (KT) candidates for predicting the development of CMV infections after transplantation.Materials and methods
All adult CMV IgG (+) recipients admitted to the KT institute between March 2014 and Ju
SUBMITTER: Kim SH
PROVIDER: S-EPMC4495268 | biostudies-literature | 2015 Jun
REPOSITORIES: biostudies-literature